Rottendorf Pharma
Markus Penassa has extensive work experience in the pharmaceutical industry. Markus started their career at HWI ANALYTIK GmbH in 2008, where they held various roles including Project Manager Laboratory Services and Deputy Head of Quality Control. Markus also served as the Responsible Person for Narcotics. In 2012, they were promoted to Deputy Head of Laboratory Services and Deputy Head of Quality Control. From 2014 to 2016, they held the position of Head of Laboratory Services, Senior Project Leader, and Deputy Head of Quality Control at HWI ANALYTIK GmbH. In 2016, Markus joined ROTTENDORF PHARMA as the Head Quality Control - Execution. Markus'smost recent position was as the Head of Quality Control - Analytics at Rottendorf Pharma, starting in 2018.
Markus Penassa pursued their education at the University of Münster from 1997 to 2008, where they obtained a Promotion degree in Analytische Chemie. Throughout their academic journey, they focused on the field of Analytical Chemistry.
In addition to their formal education, Markus Penassa also obtained various certifications to enhance their knowledge and skills. In 2014, they completed a certification program titled "Der BTM-Verantwortliche" at Concept Heidelberg. The same institution awarded him the certification for "Out-of-Trend Results" in November 2013. Furthermore, Markus attended a program called "Moderne Synthesemethoden in der Organischen Chemie für Fachkräfte aus Forschung und Entwicklung" conducted by the Gesellschaft deutscher Chemiker e. V. in September 2011.
Lastly, it is mentioned that Markus Penassa holds a Training Certificate in Project Leadership from PROPHARMACT, however, specific information regarding the completion date is not provided.
Rottendorf Pharma
1 followers
A first-class contract development and manufacturing organization (CDMO), Rottendorf Pharma has been manufacturing, packaging, developing formulations and analytical methods for solid oral dosage forms for the global pharmaceutical industry for more than 85 years. The company produces more than 600 originator and generic drug products annually for big, small, virtual, and global pharmaceutical and biotechnology companies. Rottendorf Pharma operates by the philosophy of Total Process Ownership (TPO) and Total Technological Mastering (TTM), in which we work as an extension of clients' organizations. Therefore leveraging our expertise to optimize solid dosage form production for our customers' benefit. Rottendorf Pharma has neither their own product brands in the market nor holds any product licenses, and therefore is never in competition with their clients.